Please try another search
Kiora Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, develops and commercializes therapies for the treatment of ophthalmic diseases in the United States. Its lead product is KIO-301, a potential vision-restoring small molecule, which is in Phase 1b clinical trial that acts as a photoswitch to restore vision in patients with inherited and age-related degenerative retinal diseases. The company is also developing KIO-101, an eye drop that is in Phase 2 clinical trial for the treatment of ocular presentation of rheumatoid arthritis, and KIO-104 for the treatment of posterior non-infectious uveitis; and KIO-201, an eye drop, which is in Phase 3b clinical trial for treating patients undergoing photorefractive keratectomy (PRK) surgery for corneal wound repair. The company was formerly known as Eyegate Pharmaceuticals, Inc. and changed its name to Kiora Pharmaceuticals, Inc. in November 2021. Kiora Pharmaceuticals, Inc. was incorporated in 1998 and is headquartered in Encinitas, California.
Name | Age | Since | Title |
---|---|---|---|
Daniel S. Durrie | 73 | 2017 | Member of Scientific Advisory Board |
Paul M. Karpecki | 56 | 2017 | Member of Scientific Advisory Board |
Aron Shapiro | 45 | 2021 | Director |
Brian M. Strem | 43 | 2021 | President, CEO & Director |
Praveen Tyle | 63 | 2008 | Independent Chairman of the Board |
Kenneth L. Gayron | 53 | 2021 | Independent Director |
David A. Hollander | 49 | 2021 | Independent Director |
Erin Parsons | 47 | 2022 | Non-Employee Independent Director |
Charlie Wykoff | - | - | Member of Scientific Advisory Board |
Francis Mah | - | - | Member of Scientific Advisory Board |
Allen C. Ho | - | - | Member of Scientific Advisory Board |
Christine Kay | - | - | Member of Scientific Advisory Board |
Carmine N. Stengone | 47 | 2023 | Independent Director |
Russell Van Gelder | - | - | Member of Scientific Advisory Board |
Mark Pennesi | - | 2023 | Member of Scientific Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review